241 related articles for article (PubMed ID: 22248260)
21. Synergistic interaction of adenylate cyclase activators and nitric oxide donor SIN-1 on platelet cyclic AMP.
Fisch A; Michael-Hepp J; Meyer J; Darius H
Eur J Pharmacol; 1995 May; 289(3):455-61. PubMed ID: 7556414
[TBL] [Abstract][Full Text] [Related]
22. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase.
Wu CC; Ko FN; Kuo SC; Lee FY; Teng CM
Br J Pharmacol; 1995 Oct; 116(3):1973-8. PubMed ID: 8640334
[TBL] [Abstract][Full Text] [Related]
23. Oncocalyxone A inhibits human platelet aggregation by increasing cGMP and by binding to GP Ibalpha glycoprotein.
Ferreira MA; do Nascimento NR; de Sousa CM; Pessoa OD; de Lemos TL; Ventura JS; Schattner M; Chudzinski-Tavassi AM
Br J Pharmacol; 2008 Jul; 154(6):1216-24. PubMed ID: 18516074
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of ADP-induced human platelet aggregation by a new class of soluble guanylate cyclase activators capable of nitric oxide generation.
Severina IS; Belushkina NN; Grigoryev NB
Biochem Mol Biol Int; 1994 Aug; 33(5):957-67. PubMed ID: 7987264
[TBL] [Abstract][Full Text] [Related]
25. Prolonged therapy with the soluble guanylyl cyclase activator BAY 60-2770 restores the erectile function in obese mice.
Silva FH; Leiria LO; Alexandre EC; Davel AP; Mónica FZ; De Nucci G; Antunes E
J Sex Med; 2014 Nov; 11(11):2661-70. PubMed ID: 25196910
[TBL] [Abstract][Full Text] [Related]
26. Nitric oxide-sensitive guanylyl cyclase is the only nitric oxide receptor mediating platelet inhibition.
Dangel O; Mergia E; Karlisch K; Groneberg D; Koesling D; Friebe A
J Thromb Haemost; 2010 Jun; 8(6):1343-52. PubMed ID: 20149081
[TBL] [Abstract][Full Text] [Related]
27. [The role of guanyl cyclase in the regulation of aggregation of human thrombocytes].
Chirkov IuIu; Belushkina NN; Tyshchuk IA; Severina IS
Vestn Akad Med Nauk SSSR; 1991; (10):51-4. PubMed ID: 1686950
[TBL] [Abstract][Full Text] [Related]
28. The fibrate gemfibrozil is a NO- and haem-independent activator of soluble guanylyl cyclase: in vitro studies.
Sharina IG; Sobolevsky M; Papakyriakou A; Rukoyatkina N; Spyroulias GA; Gambaryan S; Martin E
Br J Pharmacol; 2015 May; 172(9):2316-29. PubMed ID: 25536881
[TBL] [Abstract][Full Text] [Related]
29. High-fat diet-induced obesity leads to increased NO sensitivity of rat coronary arterioles: role of soluble guanylate cyclase activation.
Jebelovszki E; Kiraly C; Erdei N; Feher A; Pasztor ET; Rutkai I; Forster T; Edes I; Koller A; Bagi Z
Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2558-64. PubMed ID: 18408126
[TBL] [Abstract][Full Text] [Related]
30. In central obesity, weight loss restores platelet sensitivity to nitric oxide and prostacyclin.
Russo I; Traversa M; Bonomo K; De Salve A; Mattiello L; Del Mese P; Doronzo G; Cavalot F; Trovati M; Anfossi G
Obesity (Silver Spring); 2010 Apr; 18(4):788-97. PubMed ID: 19834474
[TBL] [Abstract][Full Text] [Related]
31. N-acetyl-L-cysteine exerts direct anti-aggregating effect on human platelets.
Anfossi G; Russo I; Massucco P; Mattiello L; Cavalot F; Trovati M
Eur J Clin Invest; 2001 May; 31(5):452-61. PubMed ID: 11380598
[TBL] [Abstract][Full Text] [Related]
32. Adenosine increases human platelet levels of cGMP through nitric oxide: possible role in its antiaggregating effect.
Anfossi G; Russo I; Massucco P; Mattiello L; Cavalot F; Balbo A; Trovati M
Thromb Res; 2002 Jan; 105(1):71-8. PubMed ID: 11864710
[TBL] [Abstract][Full Text] [Related]
33. PKC and AKT Modulate cGMP/PKG Signaling Pathway on Platelet Aggregation in Experimental Sepsis.
Lopes-Pires ME; Naime AC; Almeida Cardelli NJ; Anjos DJ; Antunes E; Marcondes S
PLoS One; 2015; 10(9):e0137901. PubMed ID: 26375024
[TBL] [Abstract][Full Text] [Related]
34. Studies on inhibition of human platelet function by sodium nitroprusside. Kinetic evaluation of the effect on aggregation and cyclic nucleotide content.
Anfossi G; Russo I; Massucco P; Mattiello L; Balbo A; Cavalot F; Trovati M
Thromb Res; 2001 May; 102(4):319-30. PubMed ID: 11369425
[TBL] [Abstract][Full Text] [Related]
35. Synergism between nitric oxide and hydrogen peroxide in the inhibition of platelet function: the roles of soluble guanylyl cyclase and vasodilator-stimulated phosphoprotein.
Sabetkar M; Naseem KM; Tullett JM; Friebe A; Koesling D; Bruckdorfer KR
Nitric Oxide; 2001 Jun; 5(3):233-42. PubMed ID: 11384196
[TBL] [Abstract][Full Text] [Related]
36. The effect of hypercholesterolemia on platelet soluble guanylyl cyclase.
Kottenberg-Assenmacher E; Weber M; Kojda G
Vascul Pharmacol; 2003 Oct; 40(3):141-7. PubMed ID: 13678645
[TBL] [Abstract][Full Text] [Related]
37. Interaction of antiplatelet drugs in vitro: aspirin, iloprost, and the nitric oxide donors SIN-1 and sodium nitroprusside.
Negrescu EV; Grünberg B; Kratzer MA; Lorenz R; Siess W
Cardiovasc Drugs Ther; 1995 Aug; 9(4):619-29. PubMed ID: 8547213
[TBL] [Abstract][Full Text] [Related]
38. Role of ascorbic acid in the modulation of inhibition of platelet aggregation by polymorphonuclear leukocytes.
Raghavan SA; Sharma P; Dikshit M
Thromb Res; 2003 May; 110(2-3):117-26. PubMed ID: 12893026
[TBL] [Abstract][Full Text] [Related]
39. In vitro inhibition of human and rat platelets by NO donors, nitrosoglutathione, sodium nitroprusside and SIN-1, through activation of cGMP-independent pathways.
Priora R; Margaritis A; Frosali S; Coppo L; Summa D; Di Giuseppe D; Aldinucci C; Pessina G; Di Stefano A; Di Simplicio P
Pharmacol Res; 2011 Sep; 64(3):289-97. PubMed ID: 21539916
[TBL] [Abstract][Full Text] [Related]
40. Nitric oxide inhibits platelet adhesion to collagen through cGMP-dependent and independent mechanisms: the potential role for S-nitrosylation.
Irwin C; Roberts W; Naseem KM
Platelets; 2009 Nov; 20(7):478-86. PubMed ID: 19852686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]